共 50 条
- [3] Hyperhomocysteinemia Due to Levodopa Treatment as a Risk Factor for Osteoporosis in Patients with Parkinson’s Disease Calcified Tissue International, 2010, 86 : 132 - 141
- [7] Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link Cellular and Molecular Neurobiology, 2023, 43 : 2743 - 2759